0001493152-19-011476.txt : 20190801
0001493152-19-011476.hdr.sgml : 20190801
20190801120128
ACCESSION NUMBER: 0001493152-19-011476
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190716
FILED AS OF DATE: 20190801
DATE AS OF CHANGE: 20190801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Al-Siddiq Waqaas
CENTRAL INDEX KEY: 0001783199
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56074
FILM NUMBER: 19991728
MAIL ADDRESS:
STREET 1: C/O 275 SHORELINE DRIVE, SUITE 150
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER NAME:
FORMER CONFORMED NAME: Al-Siqqiq Waqaas
DATE OF NAME CHANGE: 20190722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTRICITY INC.
CENTRAL INDEX KEY: 0001630113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 472548273
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 75 INTERNATIONAL BLVD., SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M9W 6L9
BUSINESS PHONE: (416) 214-3678
MAIL ADDRESS:
STREET 1: 75 INTERNATIONAL BLVD., SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M9W 6L9
FORMER COMPANY:
FORMER CONFORMED NAME: METASOLUTIONS, INC.
DATE OF NAME CHANGE: 20150107
3
1
ownership.xml
X0206
3
2019-07-16
0
0001630113
BIOTRICITY INC.
BTCY
0001783199
Al-Siddiq Waqaas
275 SHORELINE DRIVE, SUITE 150
REDWOOD CITY
CA
94065
1
1
1
0
CEO and Chairman of the Board
Common Stock
4712336
D
Options (Right to buy)
2.20
Common stock
2499998
D
Options (Right to buy)
5.44
Common stock
1300000
D
Stock options granted in July 2016 pursuant to the 2016 Equity Incentive Plan and vested in equal monthly installments beginning on July 31, 2016. The options expire five years from their vesting date.
Stock options granted on January 1, 2018 pursuant to the 2016 Equity Incentive Plan. The options began vesting equally in thirty monthly installments on January 31, 2018 and will continue to vest monthly until June 30, 2020. The options expire five years from the date of vesting and, as of the date of this filing, approximately 40% of the options remain unvested.
/s/ Waqaas Al-Siddiq
2019-08-01